Articles tagged with T Cell Activation
Researchers found that asthma causes immune cells to behave in a way that prevents brain tumor growth, suggesting a potential new therapeutic approach. The findings suggest reprogramming T cells to act like those in asthma patients could be a new treatment for brain tumors.
An international research team discovered a new rare disease caused by a disrupted Helios-dependent epigenetic regulation mechanism, leading to T and B cell defects. The study highlights the importance of Helios in immune homeostasis and suggests potential therapeutic targets for immunodeficiency and malignancy.
Researchers found that antihistamines improve responses to immune checkpoint inhibitors in cancer patients, particularly those with pre-existing allergies or high plasma histamine levels. The study suggests targeting the histamine receptor HRH1 may be a useful treatment approach.
Researchers found that activated neutrophils release proteins like galectin-9, triggering chronic inflammation and oxidative stress. Early screening for HIV is crucial, and finding ways to reduce negative effects of the infection could be key to improving outcomes.
Researchers found that certain T cells stop working before entering the tumor due to changes in gene expression, making ICB therapies less effective. Combining ICB with other forms of immunotherapy targeting different aspects of T cell function may improve response rates for non-small cell lung cancer patients.
ImCheck's ICT01 selectively activates Vγ9Vδ2 T cells through all three isoforms of BTN3A, overcoming prior limitations. The therapy demonstrates anti-tumor activity in solid and hematologic cancer models.
Researchers identified a new cell type in human skin contributing to AD and psoriasis, highlighting potential therapeutic targets. The study revealed CD14+ type 3 dendritic cells co-producing IL1B and IL23A, essential for PSO pathogenesis.
Research at TUM has discovered that non-alcoholic steatohepatitis (NASH) is caused by auto-aggressive immune cells. These cells destroy liver tissue when exposed to inflammation signals and products of fat metabolism, leading to NASH. New therapies may be developed to target this destructive immune response.
A new study reveals unique immune features of severe pediatric COVID-19, including increased activation of killer T cells and prolonged B cell frequencies. These findings may inform treatments for severe COVID-19 in children.
A potential preventative treatment for Crohn's disease has been demonstrated using a triple-punch treatment to remove T memory cells and increase T regulatory cells, preventing colitis in both mouse models and patient cells. This treatment approach may offer a new immunotherapy to prevent or ameliorate inflammatory bowel disease.
Researchers developed DNA-based nanovaccines that stimulate killer T cell immunity, resulting in tumor control. The synthetic vaccines enhanced CD8 T cell activation and induced muscle cell apoptosis, attracting macrophage infiltration and activating immune responses.
A novel acidic niche in lymph nodes regulates T cell activation, suppressing effector functions that could damage the system. The findings highlight the importance of localized acidosis in shaping T cell biology.
Rice University researchers suggest that T cell relaxation time is key to immune response, explaining how invaders prompt the immune system. The approach helps explain why T cells can react so fast and selectively, despite self-ligand imposters outnumbering invaders by a factor of 100,000.
Researchers at Temple University Health System aim to understand immunological synapse formation and its impact on T-cell activation. They will focus on the role of molecules like STIM1 and septins in shaping immune responses.
Researchers found that manipulating cellular metabolism can modulate the balance between pathogenic Th17 and regulatory T cells in chronic autoimmune disorders. A mouse model showed that inhibition of mitochondrial OXPHOS delays disease onset and reduces severity, promoting the generation of suppressive Treg cells.
Cancer cells use a camouflaging effect to escape the immune system by binding to SHP2 and PD1, activating a response switch-off mechanism. Researchers at the University of Freiburg and Leibniz University Hannover have identified this protein interaction as a target area for new treatments.
Researchers at UNC Lineberger Comprehensive Cancer Center have discovered a way to regulate co-stimulatory molecules in genetically engineered immune cells, allowing for the fine-tuning of CAR-T activity. This could lead to improved therapeutic strategies against blood cancers and potentially solid tumors.
A study by Temple-led researchers describes a unique mechanism for coordinating calcium entrance and exit 'doors' on T cells, which helps them carry out their jobs and ensure normal immune function. The research offers new insight into calcium signaling that could help scientists better understand autoimmune and immunodeficiency diseases.
Researchers identified links between genetic variants and early activation of memory T cells, suggesting problems with regulating this process could lead to immune diseases. The study's findings could help narrow down the search for molecular pathways involved in immune diseases.
Researchers found vitamin D affects dendritic cells' ability to activate T cells, hindering the activation process and reducing immune reactions. The study sheds light on how vitamin D deficiency may regulate the immune system and influence susceptibility to autoimmune diseases.
A study by CU Anschutz researchers found that men who have sex with men have unique gut microbiomes that drive immune activation and may increase their risk of HIV infection. The study suggests a direct link between microbiome composition and immune activation in HIV-negative and HIV-positive MSM.
A study found that gut microbes from high HIV-risk men who have sex with men drive immune activation in mice and HIV infection in cells. The researchers suggest that the gut microbiome might be a risk factor for HIV transmission in these individuals.
Researchers found that certain Gαs-coupled receptor agonists, including adrenaline and prostaglandin E2 and D2, prevent T cells from activating their integrins after recognizing their target. Sleep helps to decrease these molecules' levels, leading to higher integrin activation in T cells.
Researchers at MD Anderson Cancer Center have discovered a link between FGL2 protein and glioblastoma progression. FGL2, known for suppressing the immune system, is highly expressed in GBM and can be eliminated by knocking it out, eliminating tumor progression in mice with intact immune systems.
Research suggests that weakened metabolism of immune T cells, specifically one-carbon metabolism, may contribute to age-related immunity loss. Adding small-molecule compounds that boost T cell performance could potentially restore immune function.
Researchers observed age-related changes in T cell mitochondrial size and respiratory capacity. Supplementing aged mice with formate and glycine improved T cell survival and growth, suggesting potential therapeutic strategies for boosting immune responses in older individuals.
Researchers at Tokyo Institute of Technology discover CLIP-170's critical role in T cell activation by relocating the microtubule-organizing center (MTOC) to the cell surface. This process is essential for immune response initiation and could lead to improved cancer immunotherapy.
Researchers studying a rare skin disorder called DEB found that loss of collagen VII affected the cellular microenvironment, leading to abnormal mRNA and protein turnover. Meanwhile, another study used novel proteomics to characterize changes in O-GlcNAc modification sites on proteins involved in T cell activation.
Researchers at University of Utah Health identified a mechanism that activates T cells, a key component of the immune system, in patients with persistent Lyme arthritis. This activation mechanism triggers inflammation and arthritis by producing inflammatory molecules that accumulate around the joints.
Scientists have discovered that T cell activation leads to a depletion of amino acids in the blood, which in turn affects neurotransmitters serotonin and dopamine, causing anxiety and fear responses. In mice without PD-1 receptor, they found behavioral changes dominated by anxiety and exacerbated fear responses.
Researchers found that PCSK9 inhibition can reverse the effects of oxidised LDL on immune activation, leading to an anti-inflammatory state that may directly influence atherosclerosis and cardiovascular disease. This new mechanism is independent of lowering LDL cholesterol.
Research reveals that cellular stress enhances Th17 cell activation, increasing the risk of autoimmune diseases such as arthritis and multiple sclerosis. Inhibiting cellular stress may hold promise for reducing disease symptoms by preserving other T cell responses.
Researchers developed an artificial structure that can switch on immune cells to target and destroy cancer cells. The system mimics the cell membrane of antigen-presenting cells, which are responsible for activating immune responses against cancer.
Researchers at Brigham and Women's Hospital identified a distinct gene module for T cell dysfunction, contributing to chronic disease states like cancer and chronic viral infections. A transcription factor, Gata-3, was found to play a crucial role in T cell dysfunction, offering new avenues for targeted therapy.
Researchers at Helmholtz Zentrum München have identified two variants of the protein MALT1, which are regulated by posttranscriptional splicing and affect the immune response. The study found that stronger activation of T cells is associated with the MALT1A variant, while the MALT1B variant results in a weaker response.
Researchers propose that bacteria in the gut activate immune cells against proteins in the eye, leading to autoimmune uveitis. A study on mice found that eliminating gut bacteria delayed disease onset and severity, suggesting a potential therapeutic target for this condition.
Research finds gut microbes produce a molecule mimicking retinal protein, activating T cells responsible for autoimmune uveitis. The study offers a novel mechanism explaining how tissue-specific autoimmune diseases can arise from responses to gut microbes at a distal site in the body.
Higher levels of HMGB1, a 'danger' molecule fueling inflammation and blood pressure, may contribute to male hypertension. A new study suggests targeting HMGB1 could help prevent T cell activation and lower blood pressure.
Researchers at the La Jolla Institute for Allergy and Immunology report that Nuclear Factor of Activated T cells (NFAT) plays a key role in CD8 T cell exhaustion, leading to impaired immune responses. The study identifies NFAT as a molecular hub that orchestrates T cell activation and exhaustion.
Researchers discover enzyme SPPL3 activates T cells without cutting proteins, providing new insight into immune system control. The findings could also shed more light on presenilin functions and related Alzheimer's disease.
Researchers discovered that integrin loss in dendritic cells leads to increased signaling through the GM-CSF receptor, reprogramming them into a mature phenotype. This activation triggers T cell immune response, offering insights into designing targeted therapies for autoimmunity and cancer treatments.
Researchers at the University of California, San Diego School of Medicine have discovered that T-cells are activated by a pain receptor called TRPV1 channel. The study shows that this receptor helps regulate intestinal inflammation in mice, suggesting a potential new target for treating certain autoimmune disorders.
Researchers discover a molecule that causes atherosclerosis also activates white blood cells called T cells in mice, worsening autoimmune disease symptoms. This finding sheds light on the link between autoimmunity and atherosclerosis, potentially leading to improved treatments.
Researchers at Rockefeller University Press develop a novel two-pronged approach to combat glioblastoma, a highly aggressive form of brain cancer. By combining interleukin-12 with a CTLA-4 blocking drug, the cocktail successfully eradicated tumors in mice, showing promise for future treatment.
Researchers at Howard Hughes Medical Institute discovered that the pool of inactive HIV viruses in a patient's body is larger than expected, with some retaining the ability to become active even after treatment. This finding suggests that targeting the inactive viruses, known as proviruses, is crucial for achieving a complete cure.
Scientists have developed two new indicator molecules that can visualize the activation of auto-aggressive T cells in the body, shedding light on the autoimmune disease multiple sclerosis. The indicators enable researchers to track T cell activity and activation patterns in real-time, offering new avenues for drug development.
Researchers have identified a novel genetic mechanism underlying idiopathic CD4 lymphopenia, an immunodeficiency characterized by low levels of CD4 T cells. The mutation affects Unc119's ability to activate T cells and reduce Lck signaling, leading to impaired T cell proliferation.
Researchers at La Jolla Institute have identified a previously unknown molecular interaction between protein kinase C theta and CD28 that is essential for T lymphocyte activation. This discovery opens up a novel therapeutic avenue for autoimmune diseases such as multiple sclerosis and rheumatoid arthritis by blocking the cellular inter...
Researchers at The Wistar Institute have found that the protein Foxp1 actively maintains T cells in a 'quiescent state,' allowing them to work without antigenic triggers. Removing Foxp1 enables T cells to proliferate and become activated, which could lead to new treatments for diseases like cancer.
Researchers at the University of Gothenburg have discovered that superantigens, produced by staphylococcus bacteria, can activate the immune system in more ways than previously thought. This complex interaction may be behind several illnesses, including long-term wound infections and autoimmune disorders.
Researchers at Scripps Research Institute have discovered the underlying mechanisms that activate gamma delta T cells in the skin and other organs. These cells play a unique role in recognizing damage or disease in epithelial tissues, and their activation is crucial for wound healing.
Researchers found that minocycline effectively targets and reduces HIV replication in immune cells, providing an additional layer of defense against the virus. The antibiotic may improve current treatment regimens for HIV-infected patients when used in combination with HAART.
A new TB booster vaccine has been shown to improve resistance to tuberculosis in previously vaccinated adults, according to a study published by the American Thoracic Society.
Scientists have discovered that Vitamin D is essential for activating killer cells in the immune system. Without sufficient vitamin D, T cells cannot detect and fight off serious infections. The researchers found that T cells rely on vitamin D to activate and that a lack of vitamin D can lead to immune suppression.
Researchers found that periodontal pathogens activate HIV-1 promoters in T-cells, monocytes/macrophages, and dendritic cells. TLR2 and TLR9 play a key role in this response.
A new study reveals that HLA B*35-Px molecules cripple killer T cell responses, allowing HIV to progress more rapidly. This finding highlights the importance of inhibitory dendritic cell receptors in HIV-1 vaccine and therapy design.
A team of researchers has created a mouse model with key features of HIV infection, shedding light on the disease's mechanisms. The mouse exhibits symptoms similar to those of immunodeficiency virus infection, but with notable differences that highlight its limitations as a model for human disease.
A new study published in the Journal of Leukocyte Biology found that zinc activates a key protein on T cells needed to fight infections. Zinc supplementation has been shown to reduce the duration and severity of various illnesses, including childhood diarrhea and lower respiratory infections.
Research team finds that women's immune system activates more strongly in response to HIV-1, leading to higher levels of CD8+ T cell activation and faster disease progression. The study suggests that targeting this pathway may lead to new treatment strategies.
Researchers at Yale University have created nanowire sensors that can detect specific antigens and identify diseases with high sensitivity and specificity. The system uses immune cell activation to generate a current in the nanowires, allowing it to detect as few as 200 activated cells.